Company Introduction
Shenzhen Dymind Biotechnology Co., Ltd.
Founded in 2013, Shenzhen Dymind Biotechnology Co., Ltd. is a national-level high-tech enterprise specialized in R&D, production, sales and service of medical devices. Dymind headquarter is located in Shenzhen, China, with a total area of ​​25,000 square meters, more than 750 employees, and an annual output value of several hundred million RMB. Dymind is an innovation company driven by R&D. The number of R&D staff accounts for over 40%. It is led by a senior chief operating officer who has been in the business for more than 30 years. The annual R&D expenditure exceeds 20% of revenue. Dymind has applied for more than 300 national-level patents since establishment, and has the advanced R&D centers and laboratories, as well as the reagent production basement for over 3,000 square meters. Dymind has also launched the first blood + CRP all-in-one hematology analyzer in China and won a number of awards issued by the “China Medical Equipment Association”, “Medical Network ”,“Shenzhen Science and Technology Innovation Committee”. Dymind focuses on research in the blood field of in-vitro diagnostic equipment. Dymind is the first company to develop and launch the hematology analyzer + CRP all-in-one detection machine independently in China, and is an innovator of the hematology analyzer solution. The main products include 5-part hematology analyzer, 3-part hematology analyzer, veterinary hematology analyzer and the first hematology + CRP all-in-one testing machine and its reagents system. Dymind has won unanimous praise since the products launched, and ranked the second in the domestic hematology analyzer segment. The products sold to more than 120 countries and regions. Based on the continuous investment and accumulation in technological innovation, the sales have shown an exponential growth trend. Also the market performance has attracted some investment from strong capital group including Meikang Bio, Yuansheng Venture Capital, Jinyu and Sequoia.
    • 20%

      Revenue Reinvested into R&D

    • 500+

      National Patents

    • 120+

      Countries and Regions

    • 25000+

      SquareMeter Area


  • 2018
    Excellent brand
    Launched multiple new R&D projects
    Startup the “3+3 Engineering” Service Yearly Plan
    Apply for more than 200 national patents, dozens of computer software copyrights
    Dymind was awarded as the “2018 Outstanding Brand Image Award” at the 7th China Finance and Economic Summit
    Accepted investment from Sequoia Capital China Fund and Golden Domain Linked Fund
  • 2017
    Chinese first 3-part + 5-part hematology analyzer published
    Successful launched of D7-CRP and UN73
    Introduced Yuansheng Venture Capital Shares
    Become an excellent supplier of Mei Nian Health
    Awarded as the top ten IVD brands in 2017
    Accept more than 10 million yuan government grants
    Reagent Center successfully moved into Guangming New District, headquarter covers an area of more than 10,000 square meters
  • 2016
    Won the top ten brands
    Obtained the national AAA credit company certification
    Awarded the title of “Excellent Domestic Medical Equipment” by China Medical Equipment Association
    Awarded by the medical network “The Top Ten hematology analyzer Brands Approved by the clinical inspector”
    Established technical cooperation and training bases with Shenzhen University and Southern Medical University
    The production site doubled and moved to the third floor of Nanfeng Building.
Contact us
  • Adress:7-15th Floor, Building B, High-tech park, Guangqiao Road, Tianliao Community, Yutang Street, Guangming District, Shenzhen 518107 P.R. China
  • Tel:0755-26008015(Switchboard)
          0755-26008015-8568 (Domestic Marketing Center)
          0755-26008015-8123 (International Marketing Center)
  • E-mail:intl@dymind.com
COPYRIGHT@Shenzhen Dymind Biotechnology Co. LtdGuangdong ICP No. 17033936Powered by vancheer
Top

Scan the QR code to follow Dymind on Wechat